Correction to: Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders - Michael T. Nedelcovych; Boe-Hyun Kim; Xiaolei Zhu; Lyndah E. Lovell; Arena A. Manning; Jennifer Kelschenbach; Eran Hadas; Wei Chao; Eva Prchalová; Ranjeet P. Dash; Ying Wu; Jesse Alt; et al. (Journal of Neuroimmune Pharmacology, 2021)

Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders - Michael T. Nedelcovych; Boe-Hyun Kim; Xiaolei Zhu; Lyndah E. Lovell; Arena A. Manning; Jennifer Kelschenbach; Eran Hadas; Wei Chao; Eva Prchalová; Ranjeet P. Dash; Ying Wu; Jesse Alt; et al. (Journal of Neuroimmune Pharmacology, 2019)

Prostate-specific membrane antigen (PSMA)-mediated laminin proteolysis generates a pro-angiogenic peptide - Rebecca E. Conway; Camilo Rojas; Jesse Alt; Zora Nováková; Spencer M. Richardson; Tori C. Rodrick; Julio L. Fuentes; Noah H. Richardson; Jonathan Attalla; Samantha Stewart; Beshoy Fahmy; Cyril Barinka; et al. (Angiogenesis, 2016)

Neurological sequelae induced by alphavirus infection of the CNS are attenuated by treatment with the glutamine antagonist 6-diazo-5-oxo-l-norleucine - Michelle C. Potter; Victoria K. Baxter; Robert W. Mathey; Jesse Alt; Camilo Rojas; Diane E. Griffin; Barbara S. Slusher (Journal of NeuroVirology, 2015)